BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

116 hedge funds and large institutions have $380M invested in BioCryst Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 44 increasing their positions, 29 reducing their positions, and 32 closing their positions.

Holders
116
Holders Change
-17
Holders Change %
-12.78%
% of All Funds
2.52%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
17
Increased
44
Reduced
29
Closed
32
Calls
$4.84M
Puts
$4.86M
Net Calls
-$20K
Net Calls Change
-$3.09M

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$26.9M
2
State Street
2
State Street
Massachusetts
$25.2M
3
SSA
3
Schonfeld Strategic Advisors
New York
$8.47M
4
GTC
4
Ghost Tree Capital
New York
$9.48M
5
UBS Group
5
UBS Group
Switzerland
$8.35M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
GPP
2
Great Point Partners
Connecticut
$0
3
Jennison Associates
3
Jennison Associates
New York
$0
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$36.4M
5
RSCM
5
Rock Springs Capital Management
Maryland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BBA
1
Baker Bros. Advisors
New York
$54.5M 14,382,673 -735,408 -5%
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$36.4M 9,596,344 -2,661,098 -22%
BlackRock
3
BlackRock
New York
$33.8M 8,925,891 +228,525 +3%
Millennium Management
4
Millennium Management
New York
$26.9M 7,096,297 +5,539,512 +356%
Vanguard Group
5
Vanguard Group
Pennsylvania
$25.4M 6,692,444 +648,937 +11%
State Street
6
State Street
Massachusetts
$25.2M 6,645,717 +3,135,675 +89%
DM
7
Deerfield Management
New York
$23.9M 6,292,980 -244,586 -4%
Citadel Advisors
8
Citadel Advisors
Florida
$13.2M 3,492,598 +1,283,723 +58%
Fidelity Investments
9
Fidelity Investments
Massachusetts
$11M 2,894,741 -573,257 -17%
VMI
10
VHCP Management II
New York
$10.9M 2,874,602 -374,562 -12%
VMI
11
VHCP Management III
New York
$10.3M 2,708,207 -352,884 -12%
GTC
12
Ghost Tree Capital
New York
$9.48M 2,500,000 +2,000,000 +400%
SSA
13
Schonfeld Strategic Advisors
New York
$8.47M 2,233,700 +2,233,700 New
UBS Group
14
UBS Group
Switzerland
$8.35M 2,202,794 +1,691,681 +331%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$5.65M 1,491,354 +152,659 +11%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$5.63M 1,486,599 +162,090 +12%
Invesco
17
Invesco
Georgia
$5.48M 1,446,732 +563,822 +64%
Morgan Stanley
18
Morgan Stanley
New York
$5.35M 1,412,653 +1,045,869 +285%
Northern Trust
19
Northern Trust
Illinois
$5.17M 1,363,049 +2,115 +0.2%
Goldman Sachs
20
Goldman Sachs
New York
$3.81M 1,005,707 +622,093 +162%
Nuveen Asset Management
21
Nuveen Asset Management
Illinois
$3.1M 818,233 +818,233 New
Charles Schwab
22
Charles Schwab
California
$2.47M 652,733 -126,632 -16%
EU
23
Emory University
Georgia
$2.45M 645,583 +380,570 +144%
Federated Hermes
24
Federated Hermes
Pennsylvania
$2.31M 608,316 -171,090 -22%
Two Sigma Investments
25
Two Sigma Investments
New York
$2.15M 566,169 +292,561 +107%
1
2 3 4 5